Monoamine oxidase inhibitors (MAOIs) have a long and prosperous history as medications for major depressive disorder (MDD). But this type of antidepressant has mostly seen its day. Though MAOIs are ...
The FDA is notifying health care professionals that drug interactions between atorvastatin (Lipitor), rosuvastatin (Crestor), and simvastatin (Zocor) and certain protease inhibitors for HIV or ...
Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.
In 2021, the FDA found that all tested rifampin batches contained MNP levels exceeding previously accepted limits, prompting researchers to explore alternative drugs. However, these substitutes come ...
The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...
The clearance is the first in Cytokinetics’ lengthy history and pits its drug Myqorzo against Bristol Myers’ Camzyos, which ...
From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...
On May 29, 2025, the U.S. Food and Drug Administration (FDA) issued a final version of its guidance “Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback